David Schapiro, PharmD

Scientist
Eli Lilly and Company

David Schapiro is a Health Outcomes Scientist at Eli Lilly and Company. As someone personally affected by diabetes, David is deeply committed to improving the health of, and expanding the possibilities for others living with the condition.

Poster(s):

• (P110) Insulin Efsitora Alfa (Efsitora) Demonstrates Better Overall Health State vs Daily Degludec in Basal Switch Adults with T2D in QWINT-3
  Saturday, August 9, 2025

  12:00 PM - 1:00 PM MST